Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012

Drug and Alcohol Dependence

Volumn 147, Issue , 2015, Pages 215-221

  Nambiar, Dhanya ^a,b   Weir, Amanda ^c,d   Aspinall, Esther J ^c,d   Stoové, Mark ^a,b   Hutchinson, Sharon ^c,d   Dietze, Paul ^a,b   Waugh, Lynsey ^e   Goldberg, David J ^c,d  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^d HEALTH PROTECTION SCOTLAND   (United Kingdom)

^e Meridian Court   (United Kingdom)

Author keywords

Age; Cohort; Mortality; PWID; SMR

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGING; ALCOHOL LIVER DISEASE; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG OVERDOSE; FEMALE; HEALTH CARE PLANNING; HEALTH SERVICE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRAVENOUS DRUG ADMINISTRATION; LIVER CANCER; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; SCREENING TEST; SOCIAL ISOLATION; TRAFFIC ACCIDENT; UNITED KINGDOM; AGE; EPIDEMIOLOGY; HEROIN DEPENDENCE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84920982429     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.11.008     Document Type: Article

References (43)

1. Amin J., Law M.G., Bartlett M., Kaldor J.M., Dore G.J. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006, 368:938-945.
2. Aspinall E., Hutchinson S.J., Taylor A., Palmateer N., Hellard M., Allen E., Goldberg D. Uptake of paraphernalia from injecting equipment provision services and its association with sharing of paraphernalia among injecting drug users in Scotland. Drug Alcohol Depend. 2012, 126:340-346.
3. Bargagli A.M., Hickman M., Davoli M., Perucci C.A., Schifano P., Buster M., Brugal T., Vicente J., Group C.E. Drug-related mortality and its impact on adult mortality in eight European countries. Eur. J. Public Health 2006, 16:198-202.
4. Beynon C.M., McVeigh J., Roe B. Problematic drug use, ageing and older people: trends in the age of drug users in northwest England. Ageing Soc. 2007, 27:799-810.
5. Bjornaas M.A., Bekken A.S., Ojlert A., Haldorsen T., Jacobsen D., Rostrup M., Ekeberg O. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry 2008, 8:8.
6. Bloor M., Gannon M., Hay G., Jackson G., Leyland A.H., McKeganey N. Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study. Br. Med. J. 2008, 337. a478.
7. Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., García de Olalla P., de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100:981-989.
8. Cameron J., Davies R. Self-identified occupational competencies, limitations and priorities for change in the occupational lives of people with drug misuse problems. Br. J. Occup. Ther. 2010, 73. 251+.
9. Copeland L., Budd J., Robertson J.R., Elton R.A. Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001. Arch. Intern. Med. 2004, 164:1214-1220.
10. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011, 106:32-51.
11. Degenhardt L., Larney S., Randall D., Burns L., Hall W. Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction 2014, 109:90-99.
12. Degenhardt L., Singleton J., Calabria B., McLaren J., Kerr T., Mehta S., Kirk G., Hall W.D. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011, 113:88-95.
13. Frischer M., Bloor M., Goldberg D., Clark J., Green S., McKeganey N. Mortality among injecting drug users: a critical reappraisal. J. Epidemiol. Community Health 1993, 47:59-63.
14. Frischer M., Goldberg D. Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. Addiction 1997, 92:419-427.
15. Gossop M., Browne N., Stewart D., Marsden J. Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers. J. Subst. Abuse Treat. 2003, 25:135-143.
16. Gossop M., Moos R. Substance misuse among older adults: a neglected but treatable problem. Addiction 2008, 103:347-348.
17. Grebely J., Genoway K.A., Raffa J.D., Dhadwal G., Rajan T., Showler G., Kalousek K., Duncan F., Tyndall M.W., Fraser C., Conway B., Fischer B. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend. 2008, 93:141-147.
18. Horyniak D., Dietze P., Degenhardt L., Higgs P., McIlwraith F., Alati R., Bruno R., Lenton S., Burns L. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. Drug Alcohol Depend. 2013, 132:541-546.
19. Hulse G.K., English D.R., Milne E., Holman C.D. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999, 94:221-229.
20. Kielland K.B., Skaug K., Amundsen E.J., Dalgard O. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study. J. Hepatol. 2013, 58:31-37.
21. Langendam M.W., van Brussel G.H.A., Coutinho R.A., van Ameijden E.J.C. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am. J. Public Health 2001, 91:774-780.
22. Larney S., Randall D., Gibson A., Degenhardt L. The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people. Drug Alcohol Depend. 2013, 131:252-257.
23. Leyland A., Dundas R., McLoone P., Boddy F.A. Cause-specific inequalities in mortality in Scotland: two decades of change. A population-based study. BMC Public Health 2007, 7:172.
24. McDonald S.A., Hutchinson S.J., Bird S.M., Mills P.R., Hayes P., Dillon J.F., Goldberg D.J. Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006. Epidemiol. Infect. 2011, 139:344-353.
25. McDonald S.A., Hutchinson S.J., Mills P.R., Bird S.M., Robertson C., Dillon J.F., Springbett A., Goldberg D.J. Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population. Epidemiol. Infect. 2010, 138:393-402.
26. McDonald S.A., Hutchinson S.J., Wallace L.A., Cameron S.O., Templeton K., McIntyre P., Molyneaux P., Weir A., Codere G., Goldberg D.J. Trends in the incidence of HIV in Scotland, 1988-2009. Sex. Transm. Infect. 2012, 88:194-199.
27. Merrall E.L., Bird S.M., Hutchinson S.J. Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study. Int. J. Drug Policy 2012, 23:24-32.
28. Merralla E.L.C., Birda S.M., Hutchinson S.J. Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study. Int. J. Drug Policy 2012, 23:24-32.
29. Moyer V.A. Screening for hepatitis c virus infection in adults: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 2013, 159:349-357.
30. Murray M., Hogg R.S., Lima V.D., May M.T., Moore D.M., Abgrall S., Bruyand M., D'Arminio Monforte A., Tural C., Gill M.J., Harris R.J., Reiss P., Justice A., Kirk O., Saag M., Smith C.J., Weber R., Rockstroh J., Khaykin P., Sterne J.A. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Med. 2012, 13:89-97.
31. Naderi-Heiden A., Gleiss A., Bäcker C., Bieber D., Nassan-Agha H., Kasper S., Frey R. Mortality and employment after in-patient opiate detoxification. Eur. Psychiatry 2012, 27:294-300.
32. Nyhlen A., Fridell M., Hesse M., Krantz P. Causes of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006. J. Forensic Leg. Med. 2011, 18:66-72.
33. O'Kelly F.D., O'Kelly C.M. The natural history of injecting drug use: a 25-year longitudinal study of a cohort of injecting drug users in inner city Dublin. Ir. J. Med. Sci. 2012, 181:541-548.
34. Oppenheimer E., Tobutt C., Taylor C., Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994, 89:1299-1308.
35. Richardson L., Wood E., Kerr T. The impact of social, structural and physical environmental factors on transitions into employment among people who inject drugs. Soc. Sci. Med. 2013, 76:126-133.
36. Roe B., Beynon C., Pickering L., Duffy P. Experiences of drug use and ageing: health, quality of life, relationship and service implications. J. Adv. Nurs. 2010, 66:1968-1979.
37. Stoové M.A., Dietze P.M., Aitken C.K., Jolley D. Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). Drug Alcohol Depend. 2008, 96:281-285.
38. Taylor A., Goldberg D., Hutchinson S., Cameron S., Gore S.M., McMenamin J., Green S., Pithie A., Fox R. Prevalence of hepatitis c virus infection among injecting drug users in glasgow 1990-1996: are current harm reduction strategies working?. J. Infect. 2000, 40:176-183.
39. Termorshuizen F., Krol A., Prins M., van Ameijden E.J.C. Long-term outcome of chronic drug use: the amsterdam cohort study among drug users. Am. J. Epidemiol. 2005, 161:271-279.
40. Tindal C., Cook K., Foster N. Theorising stigma and the experiences of injecting drug users in Australia. Aust. J. Prim. Health 2010, 16:119-125.
41. Walter S.R., Thein H.-H., Amin J., Gidding H.F., Ward K., Law M.G., George J., Dore G.J. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J. Hepatol. 2011, 11:52.
42. Webb L., Oyefeso A., Schifano F., Cheeta S., Pollard M., Ghodse A.H. Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000. Drug Alcohol Depend. 2003, 72:67-74.
43. Zerger S. Housing: a fundamental component of drug policy. Int. J. Drug Policy 2012, 23:91-93.